ANIK · Anika Therapeutics, Inc.
$21.50
+0.33 (+1.56%)
At close · Aug 14
View the 10-Q filed Jul 29, 2026
Customer concentration
— top customer 53% of revenue
One customer — 53% of revenue (the three months ended June 30, 2026)
“Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (“J&J MedTech”), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
One customer — 50% of revenue (the six months ended June 30, 2026)
“Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (“J&J MedTech”), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
Market Cap
$287.73M
Shares
13.38M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 111,799 | 53,935 | 165,734 | 40.9% |
| 2026-06-29 | 73,631 | 25,705 | 99,336 | 34.3% |
| 2026-06-22 | 51,014 | 59,284 | 110,298 | 25.9% |
| 2026-06-15 | 48,211 | 32,324 | 80,535 | 24.2% |
| 2026-06-08 | 77,040 | 28,293 | 105,333 | 32.3% |
| 2026-06-01 | 70,286 | 41,001 | 111,287 | 38.4% |
| 2026-05-25 | 31,915 | 71,422 | 103,337 | 33.6% |
| 2026-05-18 | 53,522 | 33,030 | 86,552 | 25.5% |
| 2026-05-11 | 78,646 | 34,730 | 113,376 | 31.1% |
| 2026-05-04 | 108,032 | 92,986 | 201,018 | 35.7% |
| 2026-04-27 | 168,489 | 181,719 | 350,208 | 36.0% |
| 2026-04-20 | 154,030 | 59,176 | 213,206 | 40.6% |
| 2026-04-13 | 148,834 | 85,200 | 234,034 | 36.8% |
| 2026-04-06 | 104,839 | 78,763 | 183,602 | 31.8% |
| 2026-03-30 | 86,355 | 45,907 | 132,262 | 25.0% |
| 2026-03-23 | 147,773 | 114,458 | 262,231 | 40.6% |
| 2026-03-16 | 99,350 | 131,107 | 230,457 | 36.5% |
| 2026-03-09 | 120,530 | 95,850 | 216,380 | 33.6% |
| 2026-03-02 | 143,640 | 180,140 | 323,780 | 38.7% |
| 2026-02-23 | 190,912 | 264,554 | 455,466 | 40.6% |
| 2026-02-16 | 39,264 | 75,404 | 114,668 | 31.6% |
| 2026-02-09 | 66,336 | 90,935 | 157,271 | 31.1% |
| 2026-02-02 | 157,139 | 525,234 | 682,373 | 54.4% |
| 2026-01-26 | 184,079 | 90,072 | 274,151 | 39.1% |
| 2026-01-19 | 90,030 | 64,916 | 154,946 | 30.7% |
| 2026-01-12 | 135,607 | 104,663 | 240,270 | 36.8% |
| 2026-01-05 | 116,900 | 122,514 | 239,414 | 38.3% |
| 2025-12-29 | 72,345 | 100,994 | 173,339 | 32.7% |
| 2025-12-22 | 93,245 | 64,624 | 157,869 | 27.7% |
| 2025-12-15 | 138,866 | 287,882 | 426,748 | 41.7% |
| 2025-12-08 | 83,104 | 151,415 | 234,519 | 30.1% |
| 2025-12-01 | 136,027 | 143,628 | 279,655 | 30.4% |
| 2025-11-24 | 92,598 | 106,117 | 198,715 | 38.1% |
| 2025-11-17 | 287,130 | 238,010 | 525,140 | 46.4% |
| 2025-11-10 | 152,971 | 235,031 | 388,002 | 43.8% |
| 2025-11-03 | 121,765 | 187,886 | 309,651 | 43.4% |
| 2025-10-27 | 73,862 | 109,346 | 183,208 | 50.0% |
| 2025-10-20 | 86,138 | 157,723 | 243,861 | 42.1% |
| 2025-10-13 | 102,967 | 80,455 | 183,422 | 46.0% |
| 2025-10-06 | 88,280 | 133,502 | 221,782 | 50.6% |
| 2025-09-29 | 137,074 | 154,205 | 291,279 | 45.8% |
| 2025-09-22 | 114,448 | 90,506 | 204,954 | 38.7% |
| 2025-09-15 | 124,565 | 118,779 | 243,344 | 34.9% |
| 2025-09-08 | 75,362 | 79,320 | 154,682 | 44.4% |
| 2025-09-01 | 61,022 | 69,738 | 130,760 | 42.6% |
| 2025-08-25 | 123,364 | 196,228 | 319,592 | 51.3% |
| 2025-08-18 | 107,595 | 197,242 | 304,837 | 49.5% |
Showing 1–47 of 47 weeks
Key facts
CIK
898437
CUSIP
035255108
13F (30d)
125 filings
124 filers
Visit website
Investor relations